Preventing infectious complications when treating non‐malignant immune‐mediated hematologic disorders
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Hematology"
DOI: 10.1002/ajh.25642
Abstract: Immunosuppressants, targeted antibody therapies, and surgical splenectomy are amongst the treatment choices for immune‐mediated non‐malignant hematologic disorders, with infection being the most common non‐hematological adverse event from these therapies. Corticosteroids are associated with a length‐of‐treatment… read more here.
Keywords: preventing infectious; hematologic disorders; complications treating; immune mediated ... See more keywords